James Howard-Tripp

James Howard-Tripp

Directeur Général chez STAGEZERO LIFE SCIENCES LTD.
Health Technology
Health Services

Profil

James R.
Howard-Tripp
is currently the Executive Chairman & Chief Executive Officer at StageZero Life Sciences Ltd. He is also the Chief Executive Officer at Innovative Diagnostic Laboratory LLP, the President & Director at GeneNews (USA), Inc., and a Founding Member of the Canadian Healthcare Licensing Association.
Previously, he served as the President, Chief Executive Officer & Director at Labopharm, Inc. from 2010 to 2011.
He was also the Chief Executive Officer at Paladin Labs Europe Ltd., the President & Chief Executive Officer at Allelix Neuroscience, Inc., and the Senior Vice President-Operations at Allelix Biopharmaceuticals, Inc. Additionally, he held the position of Vice President-Business Development at Wyeth Ayerst Canada, Inc.

Postes actifs de James Howard-Tripp

SociétésPosteDébut
STAGEZERO LIFE SCIENCES LTD. Directeur Général 10/08/2016
Canadian Healthcare Licensing Association
Corporate Officer/Principal 20/08/2009
Directeur Général -
President -

Anciens postes connus de James Howard-Tripp

SociétésPosteFin
Directeur Général 14/03/2011
Directeur des opérations -
Wyeth Ayerst Canada, Inc.
Corporate Officer/Principal -
Allelix Neuroscience, Inc.
President -
Paladin Labs Europe Ltd.
President -
Voir l'expérience en détail de James Howard-Tripp

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

38

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Health Technology

Paladin Labs Europe Ltd.

Canadian Healthcare Licensing Association

Allelix Neuroscience, Inc.

Wyeth Ayerst Canada, Inc.

Health Services

Health Technology

  1. Bourse
  2. Insiders
  3. James Howard-Tripp
🔇